The next experiments, on the one hand, validated the target binding of miR-377 to RAB3C and, on the other hand, showed that RAB3C overexpression reversed the inhibitory impact of miR-377 enrichment on NSCLC cell proliferation and migration. Here, RAB3C is linked to non-small cell lung carcinoma.